Latest Articles
How companies are prioritizing women’s health in the workplace - The Business Journals
How companies are prioritizing women’s health in the workplace The Business Journals
Published: June 22, 2026, 4:53 p.m.
Optical Biopsy Offers Non-Invasive Endometrial Cancer Detection - Technology Networks
Optical Biopsy Offers Non-Invasive Endometrial Cancer Detection Technology Networks
Published: June 22, 2026, 9:27 a.m.
Lawmakers weigh ban on making workers check Slack, Teams after hours - AOL.com
Lawmakers weigh ban on making workers check Slack, Teams after hours AOL.com
Published: June 21, 2026, 6:39 a.m.
Researchers say early miscarriage risk could be linked to doing these three things at work - AOL.com
Researchers say early miscarriage risk could be linked to doing these three things at work AOL.com
Published: June 21, 2026, 3:55 a.m.
Miscarriage Risk During Early Pregnancy Linked to Bending Over Frequently, Standing and Walking at Work, in New Study - AOL.com
Miscarriage Risk During Early Pregnancy Linked to Bending Over Frequently, Standing and Walking at Work, in New Study AOL.com
Published: June 20, 2026, 9:08 a.m.
Covid-19: Rotorua MIQ worker tests positive - RNZ
Covid-19: Rotorua MIQ worker tests positive RNZ
Published: June 18, 2026, 11:44 a.m.
Worker at former Marsden Point refinery flown to hospital after medical emergency - RNZ
Worker at former Marsden Point refinery flown to hospital after medical emergency RNZ
Published: June 18, 2026, 6:20 a.m.
Leeton Shire to work with Aboriginal Land Council on future of courthouse carpark site - psnews.com.au
Leeton Shire to work with Aboriginal Land Council on future of courthouse carpark site psnews.com.au
Published: June 18, 2026, 2:34 a.m.
Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer - HMP Global Learning Network
Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer HMP Global Learning Network
Published: June 17, 2026, 8:26 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - riauone.com
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 riauone.com
Published: June 15, 2026, 12:29 p.m.
Link copied to clipboard!